Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Pharmaceuticals Corporation

This publication has 27 references indexed in Scilit: